<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="molmed"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2654848/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-Wide Association Study of Determinants of Anti-Cyclic Citrullinated Peptide Antibody Titer in Adults with Rheumatoid Arthritis</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654848/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Molecular Medicine"><meta name="citation_title" content="Genome-Wide Association Study of Determinants of Anti-Cyclic Citrullinated Peptide Antibody Titer in Adults with Rheumatoid Arthritis"><meta name="citation_authors" content="Jing Cui, Kimberly E Taylor, Anita L DeStefano, Lindsey A Criswell, Elena S Izmailova, Alex Parker, Ronenn Roubenoff, Robert M Plenge, Michael E Weinblatt, Nancy A Shadick, Elizabeth W Karlson"><meta name="citation_date" content="May-Jun 2009"><meta name="citation_issue" content="5-6"><meta name="citation_volume" content="15"><meta name="citation_firstpage" content="136"><meta name="citation_doi" content="10.2119/molmed.2009.00008"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2654848/?report=abstract"><meta name="citation_pmid" content="19287509"><meta name="DC.Title" content="Genome-Wide Association Study of Determinants of Anti-Cyclic Citrullinated Peptide Antibody Titer in Adults with Rheumatoid Arthritis"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="The Feinstein Institute for Medical Research"><meta name="DC.Contributor" content="Jing Cui"><meta name="DC.Contributor" content="Kimberly E Taylor"><meta name="DC.Contributor" content="Anita L DeStefano"><meta name="DC.Contributor" content="Lindsey A Criswell"><meta name="DC.Contributor" content="Elena S Izmailova"><meta name="DC.Contributor" content="Alex Parker"><meta name="DC.Contributor" content="Ronenn Roubenoff"><meta name="DC.Contributor" content="Robert M Plenge"><meta name="DC.Contributor" content="Michael E Weinblatt"><meta name="DC.Contributor" content="Nancy A Shadick"><meta name="DC.Contributor" content="Elizabeth W Karlson"><meta name="DC.Date" content="May-Jun 2009"><meta name="DC.Identifier" content="10.2119/molmed.2009.00008"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-Wide Association Study of Determinants of Anti-Cyclic Citrullinated Peptide Antibody Titer in Adults with Rheumatoid Arthritis"><meta property="og:type" content="article"><meta property="og:description" content="We carried out a genome-wide association study of genetic predictors of anti-cyclic citrullinated peptide antibody (anti-CCP) level in 531 self-reported non-Hispanic Caucasian Rheumatoid Arthritis (RA) patients enrolled in the Brigham Rheumatoid Arthritis ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654848/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-molmed.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2654848/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2654848/pdf/mol-15-136.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE898AE9DD4F404100000000035F023D.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2654848%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="gds">GEO DataSets</option><option value="pubmed">PubMed</option><option value="nuccore" class="last">Nucleotide</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/325/">Mol Med</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/179745/">v.15(5-6); May-Jun 2009</a></li><li class="accid">PMC2654848</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-molmed.png" alt="Logo of molmed" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://molmed.biomedcentral.com/" target="pmc_ext" ref="reftype=publisher&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Mol Med</a></span>. 2009 May-Jun; 15(5-6): 136–143. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Mar 6. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.2119%2Fmolmed.2009.00008" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.2119/molmed.2009.00008</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2654848</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19287509">19287509</a></div></div></div></div><h1 class="content-title">Genome-Wide Association Study of Determinants of Anti-Cyclic Citrullinated Peptide Antibody Titer in Adults with Rheumatoid Arthritis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Cui%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697565758560" co-class="co-affbox">Jing Cui</a>,<sup>1</sup><sup></sup> <a href="/pubmed/?term=Taylor%20KE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697563054784" co-class="co-affbox">Kimberly E Taylor</a>,<sup>2</sup> <a href="/pubmed/?term=DeStefano%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697563052672" co-class="co-affbox">Anita L DeStefano</a>,<sup>3</sup> <a href="/pubmed/?term=Criswell%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697564547104" co-class="co-affbox">Lindsey A Criswell</a>,<sup>2</sup> <a href="/pubmed/?term=Izmailova%20ES%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697564544880" co-class="co-affbox">Elena S Izmailova</a>,<sup>4</sup> <a href="/pubmed/?term=Parker%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697565114448" co-class="co-affbox">Alex Parker</a>,<sup>4</sup> <a href="/pubmed/?term=Roubenoff%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697559027872" co-class="co-affbox">Ronenn Roubenoff</a>,<sup>5</sup> <a href="/pubmed/?term=Plenge%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697559025648" co-class="co-affbox">Robert M Plenge</a>,<sup>1,</sup><sup>6</sup> <a href="/pubmed/?term=Weinblatt%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697564384192" co-class="co-affbox">Michael E Weinblatt</a>,<sup>1</sup> <a href="/pubmed/?term=Shadick%20NA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697568558512" co-class="co-affbox">Nancy A Shadick</a>,<sup>1,</sup><sup>*</sup> and  <a href="/pubmed/?term=Karlson%20EW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509" class="affpopup" co-rid="_co_idm140697568555552" co-class="co-affbox">Elizabeth W Karlson</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140697565758560"><h3 class="no_margin">Jing Cui</h3><p><sup>1</sup> Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Cui%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Jing Cui</a></div></div><div id="_co_idm140697563054784"><h3 class="no_margin">Kimberly E Taylor</h3><p><sup>2</sup> Rosalind Russell Medical Research Center for Arthritis, University of California, San Francisco, California, United States of America</p><div>Find articles by <a href="/pubmed/?term=Taylor%20KE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Kimberly E Taylor</a></div></div><div id="_co_idm140697563052672"><h3 class="no_margin">Anita L DeStefano</h3><p><sup>3</sup> School of Public Health, Boston University, Boston, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=DeStefano%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Anita L DeStefano</a></div></div><div id="_co_idm140697564547104"><h3 class="no_margin">Lindsey A Criswell</h3><p><sup>2</sup> Rosalind Russell Medical Research Center for Arthritis, University of California, San Francisco, California, United States of America</p><div>Find articles by <a href="/pubmed/?term=Criswell%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Lindsey A Criswell</a></div></div><div id="_co_idm140697564544880"><h3 class="no_margin">Elena S Izmailova</h3><p><sup>4</sup> Millennium Pharmaceuticals, Cambridge, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Izmailova%20ES%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Elena S Izmailova</a></div></div><div id="_co_idm140697565114448"><h3 class="no_margin">Alex Parker</h3><p><sup>4</sup> Millennium Pharmaceuticals, Cambridge, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Parker%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Alex Parker</a></div></div><div id="_co_idm140697559027872"><h3 class="no_margin">Ronenn Roubenoff</h3><p><sup>5</sup> Biogen Idec Inc., Cambridge, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Roubenoff%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Ronenn Roubenoff</a></div></div><div id="_co_idm140697559025648"><h3 class="no_margin">Robert M Plenge</h3><p><sup>1</sup> Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</p><p><sup>6</sup> Broad Institute, Cambridge, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Plenge%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Robert M Plenge</a></div></div><div id="_co_idm140697564384192"><h3 class="no_margin">Michael E Weinblatt</h3><p><sup>1</sup> Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Weinblatt%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Michael E Weinblatt</a></div></div><div id="_co_idm140697568558512"><h3 class="no_margin">Nancy A Shadick</h3><p><sup>1</sup> Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Shadick%20NA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Nancy A Shadick</a></div></div><div id="_co_idm140697568555552"><h3 class="no_margin">Elizabeth W Karlson</h3><p><sup>1</sup> Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</p><div>Find articles by <a href="/pubmed/?term=Karlson%20EW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287509">Elizabeth W Karlson</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140697568298944_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140697568298944_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140697568298944_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140697568298944_ai" style="display:none"><div class="fm-affl" id="af1-mol-15-136" lang="en"><sup>1</sup> Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</div><div class="fm-affl" id="af2-mol-15-136" lang="en"><sup>2</sup> Rosalind Russell Medical Research Center for Arthritis, University of California, San Francisco, California, United States of America</div><div class="fm-affl" id="af3-mol-15-136" lang="en"><sup>3</sup> School of Public Health, Boston University, Boston, Massachusetts, United States of America</div><div class="fm-affl" id="af4-mol-15-136" lang="en"><sup>4</sup> Millennium Pharmaceuticals, Cambridge, Massachusetts, United States of America</div><div class="fm-affl" id="af5-mol-15-136" lang="en"><sup>5</sup> Biogen Idec Inc., Cambridge, Massachusetts, United States of America</div><div class="fm-affl" id="af6-mol-15-136" lang="en"><sup>6</sup> Broad Institute, Cambridge, Massachusetts, United States of America</div><div id="c1-mol-15-136">Address correspondence and reprint requests to Jing Cui, Division of Rheumatology, Immunology &amp; Allergy, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis Street, PBB-B3, Boston, MA 02115. Phone: 617-732-6384; Fax: 617-731-9032; E-mail: <a href="mailto:dev@null" data-email="gro.srentrap@3iucj" class="oemail">gro.srentrap@3iucj</a>.</div><div id="fn1-mol-15-136"><sup>*</sup>NS and EWK contributed equally to this paper.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140697568298944_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Feb 26; Accepted 2009 Feb 27.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140697568298944_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  2009, The Feinstein Institute for Medical Research</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2654848/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140697563855936" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140697563855936title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">We carried out a genome-wide association study of genetic predictors of anti-cyclic citrullinated peptide antibody (anti-CCP) level in 531 self-reported non-Hispanic Caucasian Rheumatoid Arthritis (RA) patients enrolled in the Brigham Rheumatoid Arthritis Sequential Study (BRASS). For replication, we then analyzed 289 single nucleotide polymorphisms (SNPs) with <em>P</em> &lt; 0.001 in BRASS in an independent population of 849 RA patients from the North American Rheumatoid Arthritis Consortium (NARAC). BRASS and NARAC samples were genotyped using the Affymetrix 100K and Illumina 550K platforms respectively. Association between SNPs and anti-CCP titer was tested using general linear models. The five most significant SNPs from BRASS all were within the major histocompatibility complex (MHC) region (<em>P</em> ≤ 3.5 × 10<sup>−6</sup>). After controlling for the human leukocyte antigen shared epitope (HLA-SE), the top SNPs still yielded <em>P</em> values &lt; 0.0002. In NARAC, a single SNP from the MHC region near BTNL2 and HLA-DRA, rs1980493 (<em>r</em><sup>2</sup> = 0.85 with the top five SNPs from BRASS), was associated significantly with CCP titer (<em>P</em> = 6.1 × 10<sup>−5</sup>) even after adjustment for the HLA-SE (<em>P</em> = 0.0002). The top SNPs found in BRASS and NARAC had <em>r</em><sup>2</sup> = 0.46 and 0.64, respectively, to HLA-DRB1 DR3 alleles. These results confirm that the most significant genome region affecting anti-CCP titers in RA is the MHC region. We identified a SNP in moderate linkage disequilibrium (LD) with HLA-DR3, which may influence anti-CCP titer independently of the HLA-SE.</p></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">INTRODUCTION</h2><p id="__p3" class="p p-first">Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, affecting 0.5% to 1% of most populations (<a href="#b1-mol-15-136" rid="b1-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108749">1</a>). This systemic disease is marked by chronic inflammation that affects the synovial membrane of diarthrodal joints predominantly. RA is heterogeneous in terms of clinical presentation in disease aspects, progression, and severity, and in response to different clinical treatments. Its susceptibility is determined by a combination of multiple genetic and environmental factors. The most important genetic factor, which has been associated unequivocally with RA susceptibility, is variability in the major histocompatibility complex (MHC). Although the HLA associations with RA are complex (<a href="#b2-mol-15-136" rid="b2-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108733">2</a>,<a href="#b3-mol-15-136" rid="b3-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108745">3</a>), the majority of the genetic signal from the MHC is explained by alleles at the HLA-DRB1 locus (<a href="#b4-mol-15-136" rid="b4-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108735">4</a>), and accounts for approximately 30% of the genetic risk of RA (<a href="#b5-mol-15-136" rid="b5-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108744">5</a>). In individuals of European ancestry, the associated HLA-DRB1 alleles share a region of sequence similarity or “shared epitope” (SE) at amino acid positions 70–74 in the third hypervariable region of the HLA-DRB1 molecule (HLA-SE) (<a href="#b5-mol-15-136" rid="b5-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108746">5</a>).</p><p id="__p4">Anti-cyclic citrullinated peptide (anti-CCP) antibody is an important bio-marker for RA. It is as sensitive as, but more specific than, rheumatoid factor for diagnosing RA (<a href="#b6-mol-15-136" rid="b6-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108740">6</a>). Multiple studies have shown that the presence of anti-CCP antibodies in RA correlates with radiographic progression (<a href="#b6-mol-15-136" rid="b6-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108718">6</a>–<a href="#b11-mol-15-136" rid="b11-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108739">11</a>). Known genetic risk factors for RA are associated more strongly with CCP positive (CCP+) RA than with CCP negative (CCP−) RA (<a href="#b12-mol-15-136" rid="b12-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108726">12</a>–<a href="#b14-mol-15-136" rid="b14-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108721">14</a>); the most recent study by Ding <em>et al</em>. (<a href="#b14-mol-15-136" rid="b14-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108729">14</a>) definitively showed that the HLA region is associated specifically with CCP+ subset of RA. Previous studies of genetic determinants of anti-CCP have been limited to the HLA region (<a href="#b7-mol-15-136" rid="b7-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108715">7</a>,<a href="#b10-mol-15-136" rid="b10-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108725">10</a>,<a href="#b11-mol-15-136" rid="b11-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108728">11</a>, <a href="#b15-mol-15-136" rid="b15-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108722">15</a>–<a href="#b18-mol-15-136" rid="b18-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108752">18</a>). Almost all of the studies published on HLA-SE alleles and anti-CCP have the consistent finding that HLA-SE alleles are associated with CCP positivity, while some of these found that the HLA-SE is specifically associated with higher anti-CCP titer. Irigoyen <em>et al.</em> reported that HLA-DR3 is associated with lower anti-CCP titer, in contrast with HLA-SE alleles (<a href="#b16-mol-15-136" rid="b16-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108737">16</a>), using the NARAC collection.</p><p id="__p5" class="p p-last">Anti-CCP is relatively stable over time, making it a good quantitative trait to investigate. In this study, we treat anti-CCP antibody titer among RA subjects as a quantitative outcome and proxy for progressive RA in a genome-wide association study (GWAS) to elucidate the genetic basis of anti-CCP titer. Analyses were performed both with and without adjusting for HLA-SE status and HLA-DR3 to identify the additional contribution of genes other than HLA-DRB1 to variability in anti-CCP titer and severity of RA.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">METHODS</h2><div id="__sec3" class="sec sec-first"><p></p><h3 id="__sec3title" class="inline">Study Population </h3><p id="__p6" class="p p-first-last">RA patients were recruited at the Robert Breck Brigham Arthritis Center at Brigham and Women’s Hospital as described previously (<a href="#b19-mol-15-136" rid="b19-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108720">19</a>). In brief, patients were eligible to join the study if they had a diagnosis of RA, were over 18 years old, and did not have a diagnosis of pso-riatic arthritis or systemic lupus erythe-matosus. All study protocols were approved by the Brigham and Women’s Hospital Institutional Review Board and informed consent was obtained from all subjects. A total of 575 RA samples were genotyped in this study, including all CCP+ patients enrolled in the BRASS cohort at that time, and 142 CCP− patients. The cohort is predominantly female (82.3%) with a mean age of 58.0 (±13.6) years old and average disease duration of 16.1 (±12.5) years. Anti-CCP antibodies were measured using a second generation Enzyme-Linked ImmunoSorbent Assay (ELISA) from Inova (Inova Diagnostics Inc., San Diego, CA, USA).</p></div><div id="__sec4" class="sec"><p></p><h3 id="__sec4title" class="inline">Genotyping and Quality Control </h3><p id="__p7" class="p p-first">Genotyping of the samples was performed at the Broad Institute using the Affymetrix GeneChip 100K Mapping Array containing 116,204 SNPs (Affymetrix, Santa Clara, CA, USA). Samples were processed in a 96-well plate format using Biomek FX robotics according to the manufacturer’s protocol. Genotypes were called using the BRLMM (Bayesian Robust Linear Modeling using Mahalanobis distance) algorithm.</p><p id="__p8">To ensure high quality data and to minimize false positive results due to technical artifact, filtering criteria were set as follows: genotype call rate ≥ 0.95 per SNP and 0.9 per individual, minor allele frequency (MAF) ≥ 0.01, and <em>P</em> value for Hardy-Weinberg equilibrium test ≥ 0.0001. There were 97,248 autosomal SNPs from 546 self-reported Caucasians (82.3% female) that met these criteria. The average genotyping rate in the remaining individuals was 98.0%, and the SNP-wise genotyping rate was 98.9%. Samples were genotyped for HLA-SE alleles by low-resolution genotyping.</p><p id="__p9" class="p p-last">Individuals in BRASS were self-identified as Hispanic or non-Hispanic and as either Caucasian, American Native Indian, Pacific Islander/Asian, or African American. The entire study sample was utilized to screen for evidence of subtle population stratification through evaluation of pairwise identity by state (IBS) sharing distance across all samples using the software package PLINK (<a href="#b20-mol-15-136" rid="b20-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108731">20</a>). The hypothesis was that a more homogeneous population was more similar among individuals as reflected in small IBS distances. Clustering in terms of IBS-sharing distance among all possible pairs in the sample was explored through PLINK. A two-dimensional scaling plot from PLINK was used to visualize sample similarity. Standard classical multidimensional scaling was used to reduce representation of the data into two dimensions, enabling visualization on a two-axis scatter plot. Two dimensional scales (<a href="/pmc/articles/PMC2654848/figure/f1-mol-15-136/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-mol-15-136" rid-ob="ob-f1-mol-15-136" co-legend-rid="lgnd_f1-mol-15-136"><span>Figure 1</span></a>) visualized four well-separated subgroups that correlated with self-reported ethnic groups. The IBS distance between African Americans, Asians, and Caucasians was distinguished. Also, the plot suggested Hispanic Caucasians were clearly genetically different from the majority of North American Caucasians. We further checked any potential outliers among the remaining self-reported non-Hispanic Caucasians using a Cook D test for the two-dimension scale. The Cook D value for each subject is the measurement of the parameter estimate change in analysis with that subject compared with the estimate without that subject. A larger value indicates that the subject is more different from the remaining subjects (for example, an outlier). We removed 19 individuals based on IBS analysis who also self-reported Hispanic and/or non-Caucasian race. Two more individuals who self-reported as non-Hispanic Caucasian, with Cook D value &gt; 0.5 (1.07 and 0.62) were removed from analysis; the remaining subjects had a Cook D value no higher than 0.18. After quality control and removing outliers, 531 individuals were included in the genome-wide association testing.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f1-mol-15-136" co-legend-rid="lgnd_f1-mol-15-136"><a href="/pmc/articles/PMC2654848/figure/f1-mol-15-136/" target="figure" rid-figpopup="f1-mol-15-136" rid-ob="ob-f1-mol-15-136"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697569871776" class="figure"><a href="/pmc/articles/PMC2654848/figure/f1-mol-15-136/" target="figure" rid-figpopup="f1-mol-15-136" rid-ob="ob-f1-mol-15-136"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2700727_mol-15-136f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is mol-15-136f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2654848/bin/mol-15-136f1.jpg"></a></div><div id="largeobj_idm140697569871776" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/figure/f1-mol-15-136/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f1-mol-15-136"><div><a class="figpopup" href="/pmc/articles/PMC2654848/figure/f1-mol-15-136/" target="figure" rid-figpopup="f1-mol-15-136" rid-ob="ob-f1-mol-15-136">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p33">Population stratification assessments using a two-dimension plot of identity by state (IBS) distances for four self-reported ethnic groups. First and second dimension scales are shown on abscissa and ordinate respectively. Colors indicate different ethnic groups. The dimension scale results were generated from PLINK. Two individuals shown in the circles were considered outliers and excluded from further analysis.</p></div></div></div></div><div id="__sec5" class="sec"><p></p><h3 id="__sec5title" class="inline">Statistical Model </h3><p id="__p10" class="p p-first">Anti-CCP titer was used as a continuous outcome variable. For the genome-wide analysis, each SNP was tested for association with anti-CCP titer using general linear regression (GLM) assuming an additive model for all SNPs in PLINK. Secondary analyses were performed in which the HLA-SE, the well-established risk locus for anti-CCP RA, was controlled to determine whether the association was independent from the HLA-SE for SNPs on Chromosome 6. Analyses using only CCP+ (anti-CCP titer &gt; 20) subjects (N = 401) also were performed. We additionally controlled for HLA-DR3 to investigate whether the signal was independent of HLA-DR3.</p><p id="__p11">Because CCP titer was not normally distributed, simulation was used to validate the use of GLM. Ten million random genotypes were generated based on different minor allele frequencies (MAF) (0.01, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5 respectively) for each individual. The empirical <em>P</em> value distribution was obtained by analyzing observed anti-CCP measures against the simulated genotypes using GLM. A pure null distribution was simulated, in which the type I error should follow the nominal level: for example, when we use 0.05 significance level, we should expect 1/20th of the results to be significant; if we use 0.001, we should get 1 in 1000 significant results; and so on. If no excess type I error was observed, this would support the validity of the GLM test.</p><p id="__p12" class="p p-last">Permutation testing was utilized to evaluate the significance of association analysis results. Based on individual’s genome typing data, we permuted anti-CCP titer 1000 times. Then we randomly assigned genotype data to each CCP titer and ran pseudo-GWAS 1000 times to get a whole genome “association statistic.” Such permutation creates the null distribution (that is, no real associations) and hence the number of significant associations observed in the permutation analysis is a measure of the expected false positive level across the genome.</p></div><div id="__sec6" class="sec sec-last"><p></p><h3 id="__sec6title" class="inline">Replication Population </h3><p id="__p13" class="p p-first-last">Samples from the NARAC population were used for replication. NARAC samples were collected by four different study designs. NARAC cases were from multiplex families (primarily affected sibling pairs) in which at least one sibling had documented erosions. The other collections that were used for replication included samples from the National Data Bank of Rheumatic Diseases, the National Inception Cohort of Rheumatoid Arthritis, and the Study of New Onset Rheumatoid Arthritis. A more detailed description is given elsewhere (<a href="#b21-mol-15-136" rid="b21-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108743">21</a>). We genotyped 908 RA cases by SNP assay with Infinium Human Hap 550 version 1.0 (Illumina, San Diego, CA, USA) and applied the same quality control (QC) criteria as in BRASS. Among all NARAC RA patients, 849 individuals who passed QC filters, had CCP measurements, and were determined to have at least 90% European ancestry using STRUCTURE (<a href="#b22-mol-15-136" rid="b22-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108724">22</a>) were utilized in the replication analysis. For this 849-member cohort, 74.1% were female, with a mean age of 56.0 ± 12.3 years and average disease duration of 10.6 ± 11.1 years; they were all CCP+. Low resolution HLA-DRB1 typing for the allele groups DRB1*01 through DRB1*18, and high-resolution DRB1*04 typing were performed by initial PCR amplification, followed by hybridization to immobilized sequence-specific oligonucleotide probes (<a href="#b16-mol-15-136" rid="b16-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108723">16</a>). CCP was measured using the same assay as in BRASS. Different sub-cohorts had different upper ranges of the titer; in particular some titers in the NARAC family collection were truncated at 413 (4%) or 210 (1%). In the primary analysis, CCP was transformed to a normal distribution by taking the inverse normal of the rank. GLM models for the 289 550K SNPs as predictors of ordinal CCP titer were run using PLINK (<a href="#b20-mol-15-136" rid="b20-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108747">20</a>), first unadjusted and then controlling for HLA-SE status for SNPs on Chromosome 6. As sensitivity analyses for the CCP range indicated differences among the sub-cohorts, logistic models also were run with CCP categorized as high (&gt; 210) versus low (&lt; 100) and the primary GLM models were rerun with cohort and disease duration as covariates.</p></div></div><div id="__sec7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec7title">RESULTS</h2><div id="__sec8" class="sec sec-first"><p></p><h3 id="__sec8title" class="inline">Initial GWAS in BRASS </h3><p id="__p14" class="p p-first">Demographics and clinical characteristics of the final set of 531 subjects in the BRASS cohort used in the genome-wide association analysis are summarized in <a href="/pmc/articles/PMC2654848/table/t1-mol-15-136/" target="table" class="fig-table-link figpopup" rid-figpopup="t1-mol-15-136" rid-ob="ob-t1-mol-15-136" co-legend-rid=""><span>Table 1</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t1-mol-15-136"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p37">Demographics of the BRASS cohort participants with 100K genotype data meeting quality control criteria (N = 531)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697567434112" class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><tbody><tr><td rowspan="1" colspan="1" align="left">Mean age (SD)</td><td rowspan="1" colspan="1" align="center">58.0 ± 13.5</td></tr><tr><td rowspan="1" colspan="1" align="left">Mean age at RA diagnosis (SD)</td><td rowspan="1" colspan="1" align="center">41.6 ± 14.7</td></tr><tr><td rowspan="1" colspan="1" align="left">Mean y disease duration (SD)</td><td rowspan="1" colspan="1" align="center">16.4 ± 12.4</td></tr><tr><td rowspan="1" colspan="1" align="left">Female, %</td><td rowspan="1" colspan="1" align="center">82.7</td></tr><tr><td rowspan="1" colspan="1" align="left">New onset RA,<sup>a</sup> %</td><td rowspan="1" colspan="1" align="center">12.8</td></tr><tr><td colspan="2" rowspan="1" align="left">Treated with medications at baseline</td></tr><tr><td rowspan="1" colspan="1" align="left"> Methotrexate alone, %</td><td rowspan="1" colspan="1" align="center">31.1</td></tr><tr><td rowspan="1" colspan="1" align="left"> Anti-TNF alone, %</td><td rowspan="1" colspan="1" align="center">22.2</td></tr><tr><td rowspan="1" colspan="1" align="left"> Methotrexate/anti-TNF, %</td><td rowspan="1" colspan="1" align="center">17.1</td></tr><tr><td rowspan="1" colspan="1" align="left">CCP+, %</td><td rowspan="1" colspan="1" align="center">75.7</td></tr><tr><td rowspan="1" colspan="1" align="left">Anti-CCP titer, Mean (SD)</td><td rowspan="1" colspan="1" align="center">142.9 ± 121.4</td></tr><tr><td rowspan="1" colspan="1" align="left">RF+, %</td><td rowspan="1" colspan="1" align="center">76.4</td></tr><tr><td colspan="2" rowspan="1" align="left">HLA-DRB1 Shared Epitope copies, %</td></tr><tr><td rowspan="1" colspan="1" align="left"> 0</td><td rowspan="1" colspan="1" align="center">31.4</td></tr><tr><td rowspan="1" colspan="1" align="left"> 1</td><td rowspan="1" colspan="1" align="center">40.7</td></tr><tr><td rowspan="1" colspan="1" align="left"> 2</td><td rowspan="1" colspan="1" align="center">27.9</td></tr></tbody></table></div><div id="largeobj_idm140697567434112" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/table/t1-mol-15-136/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tfn1-mol-15-136"><sup>a</sup>New onset = RA onset within two years of enrollment.</div></div></div><p id="__p15">The mean age at diagnosis was 41.6 years old. Patients had well-established disease; average disease duration was 16.4 years. Frequency of 0, 1, and 2 copies of the HLA-DRB1 SE among patients were 31.4%, 40.7%, and 27.9%, respectively. Seventy-six percent were clinically classified as CCP+.</p><p id="__p16">The anti-CCP titer in the BRASS patients demonstrated a wide spectrum (from 3 to 449 units), but did not follow a normal distribution (<a href="/pmc/articles/PMC2654848/figure/f2-mol-15-136/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-mol-15-136" rid-ob="ob-f2-mol-15-136" co-legend-rid="lgnd_f2-mol-15-136"><span>Figure 2</span></a>). Skewness and kurtosis were 0.42 and −1.09 respectively, and suggest a relatively flat and long right tailed distribution. Simulation was done to evaluate whether a general linear model (GLM) would handle type I error properly. Considering minor allele frequency (MAF) values of 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5, 10 million genotypes were simulated. We observed the expected distribution of results at all α level and MAF thresholds (<a href="/pmc/articles/PMC2654848/table/t2-mol-15-136/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-mol-15-136" rid-ob="ob-t2-mol-15-136" co-legend-rid=""><span>Table 2</span></a>); no excess type I error was observed, supporting the validity of the GLM test in this analysis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f2-mol-15-136" co-legend-rid="lgnd_f2-mol-15-136"><a href="/pmc/articles/PMC2654848/figure/f2-mol-15-136/" target="figure" rid-figpopup="f2-mol-15-136" rid-ob="ob-f2-mol-15-136"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697569868768" class="figure"><a href="/pmc/articles/PMC2654848/figure/f2-mol-15-136/" target="figure" rid-figpopup="f2-mol-15-136" rid-ob="ob-f2-mol-15-136"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2700727_mol-15-136f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is mol-15-136f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2654848/bin/mol-15-136f2.jpg"></a></div><div id="largeobj_idm140697569868768" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/figure/f2-mol-15-136/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f2-mol-15-136"><div><a class="figpopup" href="/pmc/articles/PMC2654848/figure/f2-mol-15-136/" target="figure" rid-figpopup="f2-mol-15-136" rid-ob="ob-f2-mol-15-136">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p34">Anti-CCP titer distribution among 531 RA cases in BRASS. Anti-CCP titer groups are shown on the abscissa. Percentage of subjects in each group is shown on the ordinate.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t2-mol-15-136"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p39">Simulation study of observed type I error (%) for general linear models using anti-CCP titer as outcome (Tests N = 1,000,000 random genotypes)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697568907360" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th colspan="6" rowspan="1" align="center">Expected α level
<hr></th></tr><tr><th rowspan="1" colspan="1" align="left">MAF</th><th rowspan="1" colspan="1" align="center">0.01</th><th rowspan="1" colspan="1" align="center">0.001</th><th rowspan="1" colspan="1" align="center">0.0001</th><th rowspan="1" colspan="1" align="center">0.00001</th><th rowspan="1" colspan="1" align="center">0.000001</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">0.01</td><td rowspan="1" colspan="1" align="center">0.0086</td><td rowspan="1" colspan="1" align="left">0.00006</td><td rowspan="1" colspan="1" align="center">0.00007</td><td rowspan="1" colspan="1" align="left">0.0000160</td><td rowspan="1" colspan="1" align="left">0.0000008</td></tr><tr><td rowspan="1" colspan="1" align="left">0.05</td><td rowspan="1" colspan="1" align="center">0.0097</td><td rowspan="1" colspan="1" align="left">0.00009</td><td rowspan="1" colspan="1" align="center">0.00009</td><td rowspan="1" colspan="1" align="left">0.0000104</td><td rowspan="1" colspan="1" align="left">0</td></tr><tr><td rowspan="1" colspan="1" align="left">0.1</td><td rowspan="1" colspan="1" align="center">0.0098</td><td rowspan="1" colspan="1" align="left">0.00106</td><td rowspan="1" colspan="1" align="center">0.00012</td><td rowspan="1" colspan="1" align="left">0.0000160</td><td rowspan="1" colspan="1" align="left">0.0000040</td></tr><tr><td rowspan="1" colspan="1" align="left">0.2</td><td rowspan="1" colspan="1" align="center">0.0010</td><td rowspan="1" colspan="1" align="left">0.00096</td><td rowspan="1" colspan="1" align="center">0.00010</td><td rowspan="1" colspan="1" align="left">0.0000098</td><td rowspan="1" colspan="1" align="left">0.0000020</td></tr><tr><td rowspan="1" colspan="1" align="left">0.3</td><td rowspan="1" colspan="1" align="center">0.0101</td><td rowspan="1" colspan="1" align="left">0.00101</td><td rowspan="1" colspan="1" align="center">0.00011</td><td rowspan="1" colspan="1" align="left">0.0000093</td><td rowspan="1" colspan="1" align="left">0.0000021</td></tr><tr><td rowspan="1" colspan="1" align="left">0.4</td><td rowspan="1" colspan="1" align="center">0.0099</td><td rowspan="1" colspan="1" align="left">0.0010</td><td rowspan="1" colspan="1" align="center">0.00011</td><td rowspan="1" colspan="1" align="left">0.0000134</td><td rowspan="1" colspan="1" align="left">0</td></tr><tr><td rowspan="1" colspan="1" align="left">0.5</td><td rowspan="1" colspan="1" align="center">0.0100</td><td rowspan="1" colspan="1" align="left">0.0010</td><td rowspan="1" colspan="1" align="center">0.00011</td><td rowspan="1" colspan="1" align="left">0.000014</td><td rowspan="1" colspan="1" align="left">0</td></tr></tbody></table></div><div id="largeobj_idm140697568907360" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/table/t2-mol-15-136/?report=objectonly">Open in a separate window</a></div></div><p id="__p17">Genome-wide association analysis was conducted for anti-CCP titer using 97,248 SNPs in 531 BRASS samples with GLM (<a href="/pmc/articles/PMC2654848/figure/f3-mol-15-136/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-mol-15-136" rid-ob="ob-f3-mol-15-136" co-legend-rid="lgnd_f3-mol-15-136"><span>Figure 3</span></a>). The top 25 SNPs with the smallest <em>P</em> values are shown in <a href="/pmc/articles/PMC2654848/table/t3-mol-15-136/" target="table" class="fig-table-link figpopup" rid-figpopup="t3-mol-15-136" rid-ob="ob-t3-mol-15-136" co-legend-rid=""><span>Table 3</span></a>. The five most significant SNPs are in the MHC region, the well-known susceptibility region for RA, and the minor alleles all are associated with lower anti-CCP titers. After adjusting for HLA-SE status, coded as 0, 1, or 2 copies of SE allele, the association in these five SNPs remained significant (<em>P</em> &lt; 10<sup>−5</sup>) suggesting that there may be other factors in this region, besides the HLA-SE locus, that affect anti-CCP titer.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f3-mol-15-136" co-legend-rid="lgnd_f3-mol-15-136"><a href="/pmc/articles/PMC2654848/figure/f3-mol-15-136/" target="figure" rid-figpopup="f3-mol-15-136" rid-ob="ob-f3-mol-15-136"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697569128336" class="figure"><a href="/pmc/articles/PMC2654848/figure/f3-mol-15-136/" target="figure" rid-figpopup="f3-mol-15-136" rid-ob="ob-f3-mol-15-136"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2700727_mol-15-136f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is mol-15-136f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2654848/bin/mol-15-136f3.jpg"></a></div><div id="largeobj_idm140697569128336" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/figure/f3-mol-15-136/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f3-mol-15-136"><div><a class="figpopup" href="/pmc/articles/PMC2654848/figure/f3-mol-15-136/" target="figure" rid-figpopup="f3-mol-15-136" rid-ob="ob-f3-mol-15-136">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p35">Genome-wide association <em>P</em> value plots showing the association of single nucleotide polymorphism (SNPs) with Anti-CCP titers. Chromosomal location is shown on the abscissa. −10 log(p) is shown on the ordinate.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t3-mol-15-136"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p40">Top 25 most significant associations between SNPs and anti-CCP titer using general linear models for BRASS and NARAC</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697569150496" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th colspan="4" rowspan="1" align="center">BRASS
<hr></th><th colspan="3" rowspan="1" align="center">NARAC
<hr></th></tr><tr><th rowspan="1" colspan="1" align="left">Chr</th><th rowspan="1" colspan="1" align="center">100K RS number</th><th rowspan="1" colspan="1" align="center">Physical location</th><th rowspan="1" colspan="1" align="center">Gene</th><th rowspan="1" colspan="1" align="center"><em>P</em> value<sup>a</sup> from GLM</th><th rowspan="1" colspan="1" align="center"><em>P</em> value<sup>b</sup></th><th rowspan="1" colspan="1" align="center">MAF</th><th rowspan="1" colspan="1" align="center">Call Rate</th><th rowspan="1" colspan="1" align="center">550K RS number<sup>c</sup></th><th rowspan="1" colspan="1" align="center">LD <em>R</em><sup>2</sup></th><th rowspan="1" colspan="1" align="center"><em>P</em></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs2001097</td><td rowspan="1" colspan="1" align="left">32491836</td><td rowspan="1" colspan="1" align="left"><em>HLA-DRA</em></td><td rowspan="1" colspan="1" align="left">3.88E-07</td><td rowspan="1" colspan="1" align="left">0.0036</td><td rowspan="1" colspan="1" align="left">0.132</td><td rowspan="1" colspan="1" align="left">0.970</td><td rowspan="1" colspan="1" align="left">rs1980493</td><td rowspan="1" colspan="1" align="left">0.85</td><td rowspan="1" colspan="1" align="left">6.1E-05</td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs2395167</td><td rowspan="1" colspan="1" align="left">32496286</td><td rowspan="1" colspan="1" align="left"><em>BTNL2</em></td><td rowspan="1" colspan="1" align="left">5.95E-07</td><td rowspan="1" colspan="1" align="left">0.0034</td><td rowspan="1" colspan="1" align="left">0.131</td><td rowspan="1" colspan="1" align="left">0.987</td><td rowspan="1" colspan="1" align="left">rs1980493</td><td rowspan="1" colspan="1" align="left">0.85</td><td rowspan="1" colspan="1" align="left">6.1E-05</td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs2213580</td><td rowspan="1" colspan="1" align="left">32496552</td><td rowspan="1" colspan="1" align="left"><em>HLA-DRA</em></td><td rowspan="1" colspan="1" align="left">9.04E-07</td><td rowspan="1" colspan="1" align="left">0.0038</td><td rowspan="1" colspan="1" align="left">0.132</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">rs1980493</td><td rowspan="1" colspan="1" align="left">0.85</td><td rowspan="1" colspan="1" align="left">6.1E-05</td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs2001099</td><td rowspan="1" colspan="1" align="left">32491611</td><td rowspan="1" colspan="1" align="left"><em>BTNL2</em></td><td rowspan="1" colspan="1" align="left">9.78E-07</td><td rowspan="1" colspan="1" align="left">0.005</td><td rowspan="1" colspan="1" align="left">0.134</td><td rowspan="1" colspan="1" align="left">0.998</td><td rowspan="1" colspan="1" align="left">rs1980493</td><td rowspan="1" colspan="1" align="left">0.85</td><td rowspan="1" colspan="1" align="left">6.1E-05</td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs1041885</td><td rowspan="1" colspan="1" align="left">32520787</td><td rowspan="1" colspan="1" align="left"><em>HLA-DRA</em></td><td rowspan="1" colspan="1" align="left">1.07E-06</td><td rowspan="1" colspan="1" align="left">0.0027</td><td rowspan="1" colspan="1" align="left">0.134</td><td rowspan="1" colspan="1" align="left">0.996</td><td rowspan="1" colspan="1" align="left">rs1980493</td><td rowspan="1" colspan="1" align="left">0.85</td><td rowspan="1" colspan="1" align="left">6.1E-05</td></tr><tr><td rowspan="1" colspan="1" align="left">21</td><td rowspan="1" colspan="1" align="left">rs2837108</td><td rowspan="1" colspan="1" align="left">39953480</td><td rowspan="1" colspan="1" align="left"><em>C21orf8</em></td><td rowspan="1" colspan="1" align="left">9.72E-06</td><td rowspan="1" colspan="1" align="left">0.0017</td><td rowspan="1" colspan="1" align="left">0.473</td><td rowspan="1" colspan="1" align="left">0.992</td><td rowspan="1" colspan="1" align="left">rs2837108</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.8693</td></tr><tr><td rowspan="1" colspan="1" align="left">18</td><td rowspan="1" colspan="1" align="left">rs1147760</td><td rowspan="1" colspan="1" align="left">32654700</td><td rowspan="1" colspan="1" align="left"><em>C18orf1</em></td><td rowspan="1" colspan="1" align="left">2.1E-05</td><td rowspan="1" colspan="1" align="left">0.0026</td><td rowspan="1" colspan="1" align="left">0.136</td><td rowspan="1" colspan="1" align="left">0.996</td><td rowspan="1" colspan="1" align="left">rs13313604</td><td rowspan="1" colspan="1" align="left">0.908</td><td rowspan="1" colspan="1" align="left">0.9207</td></tr><tr><td rowspan="1" colspan="1" align="left">18</td><td rowspan="1" colspan="1" align="left">rs10502668</td><td rowspan="1" colspan="1" align="left">32756590</td><td rowspan="1" colspan="1" align="left"><em>KIAA132</em></td><td rowspan="1" colspan="1" align="left">2.55E-05</td><td rowspan="1" colspan="1" align="left">0.0025</td><td rowspan="1" colspan="1" align="left">0.13</td><td rowspan="1" colspan="1" align="left">0.996</td><td rowspan="1" colspan="1" align="left">rs10502668</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.9406</td></tr><tr><td rowspan="1" colspan="1" align="left">8</td><td rowspan="1" colspan="1" align="left">rs2945913</td><td rowspan="1" colspan="1" align="left">8235635</td><td rowspan="1" colspan="1" align="left">—</td><td rowspan="1" colspan="1" align="left">4.11E-05</td><td rowspan="1" colspan="1" align="left">0.0013</td><td rowspan="1" colspan="1" align="left">0.151</td><td rowspan="1" colspan="1" align="left">0.981</td><td rowspan="1" colspan="1" align="left">rs2945913</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.1276</td></tr><tr><td rowspan="1" colspan="1" align="left">5</td><td rowspan="1" colspan="1" align="left">rs2112342</td><td rowspan="1" colspan="1" align="left">116261135</td><td rowspan="1" colspan="1" align="left">—</td><td rowspan="1" colspan="1" align="left">4.34E-05</td><td rowspan="1" colspan="1" align="left">0.0026</td><td rowspan="1" colspan="1" align="left">0.368</td><td rowspan="1" colspan="1" align="left">0.998</td><td rowspan="1" colspan="1" align="left">rs2112342</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.2793</td></tr><tr><td rowspan="1" colspan="1" align="left">18</td><td rowspan="1" colspan="1" align="left">rs1445527</td><td rowspan="1" colspan="1" align="left">32769877</td><td rowspan="1" colspan="1" align="left"><em>KIAA132</em></td><td rowspan="1" colspan="1" align="left">4.93E-05</td><td rowspan="1" colspan="1" align="left">0.002</td><td rowspan="1" colspan="1" align="left">0.132</td><td rowspan="1" colspan="1" align="left">0.983</td><td rowspan="1" colspan="1" align="left">rs13313604</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.9207</td></tr><tr><td rowspan="1" colspan="1" align="left">18</td><td rowspan="1" colspan="1" align="left">rs2017027</td><td rowspan="1" colspan="1" align="left">33059192</td><td rowspan="1" colspan="1" align="left"><em>KIAA132</em></td><td rowspan="1" colspan="1" align="left">5.07E-05</td><td rowspan="1" colspan="1" align="left">0.004</td><td rowspan="1" colspan="1" align="left">0.13</td><td rowspan="1" colspan="1" align="left">0.996</td><td rowspan="1" colspan="1" align="left">rs13313604</td><td rowspan="1" colspan="1" align="left">0.81</td><td rowspan="1" colspan="1" align="left">0.9207</td></tr><tr><td rowspan="1" colspan="1" align="left">9</td><td rowspan="1" colspan="1" align="left">rs4877406</td><td rowspan="1" colspan="1" align="left">87990359</td><td rowspan="1" colspan="1" align="left"><em>SPIN</em></td><td rowspan="1" colspan="1" align="left">6.32E-05</td><td rowspan="1" colspan="1" align="left">0.0005</td><td rowspan="1" colspan="1" align="left">0.276</td><td rowspan="1" colspan="1" align="left">0.964</td><td rowspan="1" colspan="1" align="left">rs4877406</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.9854</td></tr><tr><td rowspan="1" colspan="1" align="left">4</td><td rowspan="1" colspan="1" align="left">rs842873</td><td rowspan="1" colspan="1" align="left">73061500</td><td rowspan="1" colspan="1" align="left"><em>GPR74</em></td><td rowspan="1" colspan="1" align="left">7.78E-05</td><td rowspan="1" colspan="1" align="left">0.0007</td><td rowspan="1" colspan="1" align="left">0.44</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">—<sup>c</sup></td><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="left"></td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs10484713</td><td rowspan="1" colspan="1" align="left">140662577</td><td rowspan="1" colspan="1" align="left">—</td><td rowspan="1" colspan="1" align="left">0.000104</td><td rowspan="1" colspan="1" align="left">0.0146</td><td rowspan="1" colspan="1" align="left">0.255</td><td rowspan="1" colspan="1" align="left">0.977</td><td rowspan="1" colspan="1" align="left">rs10457702</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.6854</td></tr><tr><td rowspan="1" colspan="1" align="left">18</td><td rowspan="1" colspan="1" align="left">rs10502669</td><td rowspan="1" colspan="1" align="left">32758505</td><td rowspan="1" colspan="1" align="left"><em>KIAA132</em></td><td rowspan="1" colspan="1" align="left">0.000106</td><td rowspan="1" colspan="1" align="left">0.0052</td><td rowspan="1" colspan="1" align="left">0.132</td><td rowspan="1" colspan="1" align="left">0.994</td><td rowspan="1" colspan="1" align="left">rs13313604</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.9207</td></tr><tr><td rowspan="1" colspan="1" align="left">5</td><td rowspan="1" colspan="1" align="left">rs10514299</td><td rowspan="1" colspan="1" align="left">87699366</td><td rowspan="1" colspan="1" align="left"><em>MGC3321</em></td><td rowspan="1" colspan="1" align="left">0.000116</td><td rowspan="1" colspan="1" align="left">0.021</td><td rowspan="1" colspan="1" align="left">0.239</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">rs10514299</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.4791</td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs5000563</td><td rowspan="1" colspan="1" align="left">32512113</td><td rowspan="1" colspan="1" align="left"><em>HLA-DRA</em></td><td rowspan="1" colspan="1" align="left">0.000128</td><td rowspan="1" colspan="1" align="left">0.028</td><td rowspan="1" colspan="1" align="left">0.254</td><td rowspan="1" colspan="1" align="left">0.994</td><td rowspan="1" colspan="1" align="left">rs2395174</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.883</td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs1357056</td><td rowspan="1" colspan="1" align="left">122405433</td><td rowspan="1" colspan="1" align="left"><em>GJA1</em></td><td rowspan="1" colspan="1" align="left">0.00014</td><td rowspan="1" colspan="1" align="left">0.0044</td><td rowspan="1" colspan="1" align="left">0.063</td><td rowspan="1" colspan="1" align="left">0.998</td><td rowspan="1" colspan="1" align="left">rs2684265</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.5603</td></tr><tr><td rowspan="1" colspan="1" align="left">11</td><td rowspan="1" colspan="1" align="left">rs313877</td><td rowspan="1" colspan="1" align="left">102830195</td><td rowspan="1" colspan="1" align="left"><em>DDI1</em></td><td rowspan="1" colspan="1" align="left">0.000141</td><td rowspan="1" colspan="1" align="left">0.0132</td><td rowspan="1" colspan="1" align="left">0.194</td><td rowspan="1" colspan="1" align="left">0.985</td><td rowspan="1" colspan="1" align="left">rs1481980</td><td rowspan="1" colspan="1" align="left">0.958</td><td rowspan="1" colspan="1" align="left">0.1932</td></tr><tr><td rowspan="1" colspan="1" align="left">5</td><td rowspan="1" colspan="1" align="left">rs2056403</td><td rowspan="1" colspan="1" align="left">52399256</td><td rowspan="1" colspan="1" align="left"><em>ITGA2</em></td><td rowspan="1" colspan="1" align="left">0.000156</td><td rowspan="1" colspan="1" align="left">0.0026</td><td rowspan="1" colspan="1" align="left">0.257</td><td rowspan="1" colspan="1" align="left">0.983</td><td rowspan="1" colspan="1" align="left">rs1421933</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.7621</td></tr><tr><td rowspan="1" colspan="1" align="left">5</td><td rowspan="1" colspan="1" align="left">rs390856</td><td rowspan="1" colspan="1" align="left">87583315</td><td rowspan="1" colspan="1" align="left"><em>MGC3321</em></td><td rowspan="1" colspan="1" align="left">0.000165</td><td rowspan="1" colspan="1" align="left">0.0215</td><td rowspan="1" colspan="1" align="left">0.241</td><td rowspan="1" colspan="1" align="left">0.998</td><td rowspan="1" colspan="1" align="left">rs10514299</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.4791</td></tr><tr><td rowspan="1" colspan="1" align="left">3</td><td rowspan="1" colspan="1" align="left">rs10510617</td><td rowspan="1" colspan="1" align="left">28989642</td><td rowspan="1" colspan="1" align="left"><em>RBMS3</em></td><td rowspan="1" colspan="1" align="left">0.000174</td><td rowspan="1" colspan="1" align="left">0.0017</td><td rowspan="1" colspan="1" align="left">0.48</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">rs6768946</td><td rowspan="1" colspan="1" align="left">0.869</td><td rowspan="1" colspan="1" align="left">0.07224</td></tr><tr><td rowspan="1" colspan="1" align="left">4</td><td rowspan="1" colspan="1" align="left">rs1246590</td><td rowspan="1" colspan="1" align="left">75463744</td><td rowspan="1" colspan="1" align="left">—-</td><td rowspan="1" colspan="1" align="left">0.000182</td><td rowspan="1" colspan="1" align="left">0.0084</td><td rowspan="1" colspan="1" align="left">0.252</td><td rowspan="1" colspan="1" align="left">0.981</td><td rowspan="1" colspan="1" align="left">rs1265327</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.6153</td></tr><tr><td rowspan="1" colspan="1" align="left">6</td><td rowspan="1" colspan="1" align="left">rs6922541</td><td rowspan="1" colspan="1" align="left">135524512</td><td rowspan="1" colspan="1" align="left"><em>HBS1L</em></td><td rowspan="1" colspan="1" align="left">0.000189</td><td rowspan="1" colspan="1" align="left">0.0034</td><td rowspan="1" colspan="1" align="left">0.404</td><td rowspan="1" colspan="1" align="left">0.981</td><td rowspan="1" colspan="1" align="left">rs6922541</td><td rowspan="1" colspan="1" align="left">1</td><td rowspan="1" colspan="1" align="left">0.4497</td></tr></tbody></table></div><div id="largeobj_idm140697569150496" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2654848/table/t3-mol-15-136/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tfn2-mol-15-136"><sup>a</sup><em>P</em> value from GLM using all BRASS subjects, N = 531.</div><div id="tfn3-mol-15-136"><sup>b</sup><em>P</em> value from GLM using only CCP+ subjects, N = 401.</div><div id="tfn4-mol-15-136"><sup>c</sup>550K entries did not have a tagging SNP on 550K genotyping platform.</div></div></div><p id="__p18">The primary results suggest that five SNPs in the HLA region are associated with CCP titer; however, this could be interpreted as an HLA association with CCP positivity rather than titer since CCP− subjects were included in the analysis. To test whether these findings are robust, we limited the analysis to 401 CCP+ RA subjects in a secondary analysis. The associations still held with slightly weaker <em>P</em> values, suggesting that these SNPs are associated with CCP level among those who are CCP+, not just with CCP positivity (<a href="/pmc/articles/PMC2654848/table/t3-mol-15-136/" target="table" class="fig-table-link figpopup" rid-figpopup="t3-mol-15-136" rid-ob="ob-t3-mol-15-136" co-legend-rid=""><span>Table 3</span></a>).</p><p id="__p19" class="p p-last">Permutation analyses to examine the expected number of false positive findings with observed associations are summarized in <a href="/pmc/articles/PMC2654848/table/t4-mol-15-136/" target="table" class="fig-table-link figpopup" rid-figpopup="t4-mol-15-136" rid-ob="ob-t4-mol-15-136" co-legend-rid=""><span>Table 4</span></a> for two genotype success rates. For SNPs with a genotype rate greater than 95%, we observed 134 tests that reached significance at the level of &lt; 0.001; by random chance we would expect 93 significant tests. Furthermore, a Q-Q plot (<a href="/pmc/articles/PMC2654848/figure/f4-mol-15-136/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-mol-15-136" rid-ob="ob-f4-mol-15-136" co-legend-rid="lgnd_f4-mol-15-136"><span>Figure 4</span></a>) demonstrated no excess signals that might be due to bias based on a genotype call rate of 95%.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f4-mol-15-136" co-legend-rid="lgnd_f4-mol-15-136"><a href="/pmc/articles/PMC2654848/figure/f4-mol-15-136/" target="figure" rid-figpopup="f4-mol-15-136" rid-ob="ob-f4-mol-15-136"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697562750352" class="figure"><a href="/pmc/articles/PMC2654848/figure/f4-mol-15-136/" target="figure" rid-figpopup="f4-mol-15-136" rid-ob="ob-f4-mol-15-136"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2700727_mol-15-136f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is mol-15-136f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2654848/bin/mol-15-136f4.jpg"></a></div><div id="largeobj_idm140697562750352" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/figure/f4-mol-15-136/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f4-mol-15-136"><div><a class="figpopup" href="/pmc/articles/PMC2654848/figure/f4-mol-15-136/" target="figure" rid-figpopup="f4-mol-15-136" rid-ob="ob-f4-mol-15-136">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p36">Quantile-Quantile plot (Q-Q) showing the comparison between whole genome association observed −log10(p) and expected –log10(p). Expected –log10(p) assumes there is no association between SNPs with anti-CCP and shown on the abscissa. The observed –log10(p) is shown on the ordinate.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t4-mol-15-136"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p44">Observed number of significant associations compared with expected associations by permutation testing</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697568317424" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left"></th><th rowspan="1" colspan="1" align="center"></th><th colspan="4" rowspan="1" align="center">Observed N
<hr></th></tr><tr><th rowspan="1" colspan="1" align="left">Genotype rate</th><th rowspan="1" colspan="1" align="center">SNP N</th><th rowspan="1" colspan="1" align="center">&lt;0.01</th><th rowspan="1" colspan="1" align="center">&lt;0.001</th><th rowspan="1" colspan="1" align="center">&lt;0.0001</th><th rowspan="1" colspan="1" align="center">&lt;0.00001</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">95%</td><td rowspan="1" colspan="1" align="center">93709</td><td rowspan="1" colspan="1" align="center">1114</td><td rowspan="1" colspan="1" align="center">134</td><td rowspan="1" colspan="1" align="center">14</td><td rowspan="1" colspan="1" align="center">6</td></tr><tr><td rowspan="1" colspan="1" align="left">99%</td><td rowspan="1" colspan="1" align="center">59885</td><td rowspan="1" colspan="1" align="center">690</td><td rowspan="1" colspan="1" align="center">78</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="center">4</td></tr><tr><td colspan="6" rowspan="1" align="left"><hr></td></tr><tr><td rowspan="1" colspan="1" align="left"></td><td rowspan="1" colspan="1" align="center"></td><td colspan="4" rowspan="1" align="center">Corresponded expected N
<hr></td></tr><tr><td rowspan="1" colspan="1" align="left">95%</td><td rowspan="1" colspan="1" align="center">93709</td><td rowspan="1" colspan="1" align="center">932.5</td><td rowspan="1" colspan="1" align="center">93.2</td><td rowspan="1" colspan="1" align="center">8.1</td><td rowspan="1" colspan="1" align="center">0.9</td></tr><tr><td rowspan="1" colspan="1" align="left">99%</td><td rowspan="1" colspan="1" align="center">59885</td><td rowspan="1" colspan="1" align="center">596.0</td><td rowspan="1" colspan="1" align="center">59.7</td><td rowspan="1" colspan="1" align="center">5.8</td><td rowspan="1" colspan="1" align="center">0.6</td></tr></tbody></table></div><div id="largeobj_idm140697568317424" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/table/t4-mol-15-136/?report=objectonly">Open in a separate window</a></div></div></div><div id="__sec9" class="sec sec-last"><p></p><h3 id="__sec9title" class="inline">Replication Analysis in NARAC </h3><p id="__p20" class="p p-first">We selected 289 SNPs that were associated with anti-CCP titer in all BRASS cohort or CCP+ cohort at <em>P</em> ≤ 0.001 to assess replication in the NARAC Illumina 550K data set. We compared the two genotyping platforms using HapMap linkage disequilibrium (LD) information (<a href="#b23-mol-15-136" rid="b23-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108714">23</a>) to define proxy SNPs for replication. There were 289 tagging SNPs in the 550K panel that passed quality control (QC) and tagged one or more candidate SNPs with <em>r</em><sup>2</sup> &gt; 0.8 in the Hap Map CEU population (<a href="#b24-mol-15-136" rid="b24-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108738">24</a>). Among the SNPs analyzed in the NARAC sample, the most significant was rs1980493, which is in LD with the top five SNPs from BRASS (<em>R</em><sup>2</sup> = 0.85) (unadjusted GLM <em>P</em> = 6.1 × 10<sup>−5</sup> [<a href="/pmc/articles/PMC2654848/table/t3-mol-15-136/" target="table" class="fig-table-link figpopup" rid-figpopup="t3-mol-15-136" rid-ob="ob-t3-mol-15-136" co-legend-rid=""><span>Table 3</span></a>], and SE-adjusted <em>P</em> = 0.00018). The minor allele was associated with lower anti-CCP levels. In sensitivity analyses to test for differences in subcohort CCP ranges (see Methods), rs1980493 remained the top SNP (GLM adjusted for HLA-SE, cohort, and disease duration, <em>P</em> = 0.0003; logistic regression of high/ low CCP subsets, <em>P</em> = 0.003). This SNP is located between HLA-DRA and the gene BTNL2. Two more candidate SNPs, rs12478948 and rs2046159, achieved a <em>P</em> value of &lt; 0.01 in the NARAC study (data not shown).</p><p id="__p21">Additional exploration of the HLA region was performed using BRASS data. Because the HLA-SE is actually a group of alleles in the HLA-DRB1 region, when we checked LD between the five identified SNPs with individual SE alleles DR1 and DR4, the highest LD <em>r</em><sup>2</sup> with SE risk alleles observed was 0.09. We also examined LD defining HLA-SE as any copy of SE alleles and found an <em>r</em><sup>2</sup> = 0.14 (<a href="/pmc/articles/PMC2654848/table/t5-mol-15-136/" target="table" class="fig-table-link figpopup" rid-figpopup="t5-mol-15-136" rid-ob="ob-t5-mol-15-136" co-legend-rid=""><span>Table 5</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t5-mol-15-136"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="__p45">Association between HLA-DRB1 alleles and anti-CCP titer, and LD with the most strongly associated SNP</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140697564321712" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left">DRB1 allele</th><th rowspan="1" colspan="1" align="center">Association with anti-CCP, <em>P</em> value</th><th rowspan="1" colspan="1" align="center">LD with SNP rs1041885 (<em>R</em><sup>2</sup>)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">DR1</td><td rowspan="1" colspan="1" align="center">0.3531</td><td rowspan="1" colspan="1" align="center">0.0296</td></tr><tr><td rowspan="1" colspan="1" align="left">DR2</td><td rowspan="1" colspan="1" align="center">0.1025</td><td rowspan="1" colspan="1" align="center">0.0019</td></tr><tr><td rowspan="1" colspan="1" align="left">DR3</td><td rowspan="1" colspan="1" align="center">0.0003</td><td rowspan="1" colspan="1" align="center">0.4621</td></tr><tr><td rowspan="1" colspan="1" align="left">DR4</td><td rowspan="1" colspan="1" align="center">4 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">0.0935</td></tr><tr><td rowspan="1" colspan="1" align="left">DR7</td><td rowspan="1" colspan="1" align="center">0.5409</td><td rowspan="1" colspan="1" align="center">0.0119</td></tr><tr><td rowspan="1" colspan="1" align="left">DR11_DR13</td><td rowspan="1" colspan="1" align="center">0.0184</td><td rowspan="1" colspan="1" align="center">0.0353</td></tr><tr><td rowspan="1" colspan="1" align="left">SE<sup>a</sup></td><td rowspan="1" colspan="1" align="center">2 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">0.1447</td></tr></tbody></table></div><div id="largeobj_idm140697564321712" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2654848/table/t5-mol-15-136/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tfn5-mol-15-136"><sup>a</sup>DR1 and DR4 are known HLA-SE for RA.</div></div></div><p id="__p22" class="p p-last">A previous study demonstrated an inverse association between HLA-DR3 and anti-CCP titer (<a href="#b16-mol-15-136" rid="b16-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108736">16</a>) in NARAC subjects. The five top SNPs in BRASS had an <em>r</em><sup>2</sup> = 0.46 with DR3. We repeated the analysis adjusting for HLA-DR3 and the <em>P</em> value for the top five SNPs in BRASS were 0.0002 (data not shown). Among the CCP + BRASS subjects, the <em>P</em> values were 0.01. The <em>P</em> value for the single top SNP in NARAC was 0.6 after adjusting for DR3. The P value for a heterogeneity test between BRASS and NARAC was 0.23 for the top SNP. We then pooled the raw data and performed a pooled meta-analysis across the BRASS and NARAC studies, and the SNP rs1980493 was associated significantly with anti-CCP titer at 1.8 × 10<sup>−9</sup>, 5.3 × 10<sup>−7</sup>, 0.0014, and 0.0022 for unadjusted model, adjusted for HLA-SE, adjusted for HLA-DR3, and adjusted for both HLA-SE and DR3 in the same model respectively. When limiting BRASS to CCP+ only (N = 401) and pooling with NARAC for the same four analyses, results were 2.9 × 10<sup>−7</sup>, 1.0 × 10<sup>−6</sup>, 0.02, 0.01, respectively.</p></div></div><div id="__sec10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec10title">DISCUSSION</h2><p id="__p23" class="p p-first">We performed GWAS on the quantitative RA trait of anti-CCP titer and confirmed that HLA is the most important region for this RA phenotype. However, the HLA-SE does not explain all the risk in the region, as there is a significant signal in the region that is independent of HLA-SE status. The minor alleles of the top SNPs in both cohorts are associated inversely with anti-CCP level. This signal, near BTNL2 and HLA-DRA, is in LD with HLA-DR3; therefore, the precise causal location of this effect remains to be determined.</p><p id="__p24">Besides genetic susceptibility analysis in RA, there also are studies of genetic associations for anti-CCP level as a quantitative trait. Most of these studies focused on the HLA region (<a href="#b7-mol-15-136" rid="b7-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108748">7</a>,<a href="#b10-mol-15-136" rid="b10-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108727">10</a>,<a href="#b11-mol-15-136" rid="b11-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108719">11</a>, <a href="#b15-mol-15-136" rid="b15-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108750">15</a>–<a href="#b18-mol-15-136" rid="b18-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108716">18</a>), and consistently found that the HLA-SE is associated with higher anti-CCP titer. Irigoyen <em>et al.</em> reported that in contrast to the SE, HLA-DR3 alleles were found to be associated with lower anti-CCP titers. The top SNPs from BRASS have moderate LD with DR3, also are associated with lower anti-CCP titers, and the association holds after adjustment for DR3. The proxy SNP from NARAC has higher LD with DR3 (<em>r</em><sup>2</sup> = 0.64, with D’≈ 1), and, after adjusting for DR3, the association is no longer significant. We do see significant association between the top SNP and anti-CCP titer after controlling for DR3 in the combined cohort. Although our results support independence of the SNP from the HLA-SE, further evidence will be needed to determine whether the SNP is associated with anti-CCP independent of HLA-DR3.</p><p id="__p25">Aside from traditional linkage and candidate gene studies, the availability of cost effective high-throughput SNP genotyping platform technology has generated high enthusiasm for GWAS for a wide range of disorders. Among these, four were done within several large RA case-control studies looking for RA risk loci (<a href="#b13-mol-15-136" rid="b13-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108741">13</a>,<a href="#b21-mol-15-136" rid="b21-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108753">21</a>,<a href="#b25-mol-15-136" rid="b25-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108742">25</a>,<a href="#b26-mol-15-136" rid="b26-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108751">26</a>). Remmers <em>et al.</em> (<a href="#b25-mol-15-136" rid="b25-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108732">25</a>) reported that a STAT4 SNP, rs7574865,was associated significantly with RA risk in two large cohorts. There were two SNPs on the 100K SNP platform, rs3821236 and rs3024886, in LD with STAT4 rs7574865 with <em>R</em><sup>2</sup> of 0.74; however, we failed to find any association with anti-CCP titer. For non-MHC reported regions from WTCCC (<a href="#b26-mol-15-136" rid="b26-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108717">26</a>) that associated with RA risk, we did see signals from Chromosomes 6q, 21, and 22 in analysis of BRASS samples, but failed to replicate these results in the NARAC samples. Plenge <em>et al.</em>(<a href="#b21-mol-15-136" rid="b21-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108734">21</a>) reported that SNPs in LD with the TRAF1 and C5 genes were associated significantly with RA, and Raychaudhuri <em>et al.</em>(<a href="#b27-mol-15-136" rid="b27-mol-15-136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_224108730">27</a>) reported new risk loci for RA, CD40 and CCL21 from meta analysis. However, in the 100K SNP platform, none of the available SNPs are in high LD with the reported SNPs.</p><p id="__p26">An important strength of this study is the inclusion of two large, well-characterized RA cohorts. Limitations include the risk of false positive findings due to the large number of tests inherent in genome-wide association testing. Therefore, it is crucial to confirm findings by replication studies. We included 130 CCP− subjects from BRASS in the primary analysis which raises the question of whether the significant associations in the HLA region are due to an HLA association with the CCP positive/negative phenotype. However, in a secondary analysis limited to CCP+ subjects only, our findings were similar, suggesting that the association with CCP titer is robust. Although we have a fairly homogeneous cohort with a sample size &gt;500, we still lack power to detect loci with small effect sizes. The 100K SNP platform only covers ~20% of the common variants through the genome, so more comprehensive sets of SNPs are needed for a better understanding of the genetic basic of the quantitative trait anti-CCP titer.</p><p id="__p27" class="p p-last">After testing our top findings in NARAC sample, we identified a locus in the HLA-DRA/BTNL2 region in LD with DR3 with a strong signal in both samples. After adjustment for HLA-SE status, this signal remained significant at <em>P</em> = 5.3 × 10<sup>−7</sup>, suggesting a signal in this region that is independent of the HLA-SE.</p></div><div id="idm140697566812160" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140697566812160title">ACKNOWLEDGMENTS</h2><div class="sec"><p id="__p28">The BRASS Registry is supported by a grant from Millennium Pharmaceuticals, Biogen-Idec, and Crescendo Biosciences. The NARAC is supported by US National Institutes of Health grants R01-AR44422, M01 RR-00079, and NO1-AR-2-2263. J Cui is supported by NIH grants R01 AR49880, P60 AR047782, and the Alliance for Lupus Research. LA Criswell is supported by NIH grants K24 AR02175 and R01 AI065841. RM Plenge is supported by a NIH K08 AI55314-3, a private donation from the Fox Trot Fund, the Burroughs Wellcome Fund, and the William Ran-dolph Hearst Fund of Harvard University. EW Karlson is supported by NIH grants R01 AR49880, P60 AR047782, and K24 AR0524-01. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. We thank all participants and Investigators from BRASS and NARAC, especially the principle investigator Peter K Gregersen.</p></div></div><div id="idm140697566810352" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140697566810352title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140697566810224"></p><p id="__p29" class="p p-first-last">Online address: <a href="http://www.molmed.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.molmed.org</a></p><p></p><p class="fn sec" id="idm140697566808624"></p><p id="__p30" class="p p-first-last">Epub (<a href="http://www.molmed.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.molmed.org</a>) ahead of print March 6, 2009.</p><p></p><p class="fn sec" id="idm140697564431152"></p><p id="__p31" class="p p-first"><strong>DISCLOSURE</strong></p><p id="__p32" class="p p-last">The BRASS registry is supported by a research grant from Millenninum Pharmaceuticals, Biogen-Idec, and Crescendo Bioscience. E Izmailova and A Parker are employed at Millennium. R Roubenoff is employed at Biogen.</p><p></p></div></div><div id="idm140697564429680" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140697564429680title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1-mol-15-136">1. <span class="element-citation">Gabriel SE, Crowson CS, O’Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. <span><span class="ref-journal">Arthritis Rheum. </span>1999;<span class="ref-vol">42</span>:415–20.</span> [<a href="/pubmed/10088762" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=The+epidemiology+of+rheumatoid+arthritis+in+Rochester,+Minnesota,+1955–1985&amp;author=SE+Gabriel&amp;author=CS+Crowson&amp;author=WM+O’Fallon&amp;volume=42&amp;publication_year=1999&amp;pages=415-20&amp;pmid=10088762&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2-mol-15-136">2. <span class="element-citation">Jawaheer D, Gregersen PK. Rheumatoid arthritis. The genetic components. <span><span class="ref-journal">Rheum Dis Clin North Am. </span>2002;<span class="ref-vol">28</span>:1–15. v.</span> [<a href="/pubmed/11840692" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheum+Dis+Clin+North+Am&amp;title=Rheumatoid+arthritis.+The+genetic+components&amp;author=D+Jawaheer&amp;author=PK+Gregersen&amp;volume=28&amp;publication_year=2002&amp;pages=1-15&amp;pmid=11840692&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3-mol-15-136">3. <span class="element-citation">Newton JL, Harney SM, Wordsworth BP, Brown MA. A review of the MHC genetics of rheumatoid arthritis. <span><span class="ref-journal">Genes Immun. </span>2004;<span class="ref-vol">5</span>:151–7.</span> [<a href="/pubmed/14749714" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Immun&amp;title=A+review+of+the+MHC+genetics+of+rheumatoid+arthritis&amp;author=JL+Newton&amp;author=SM+Harney&amp;author=BP+Wordsworth&amp;author=MA+Brown&amp;volume=5&amp;publication_year=2004&amp;pages=151-7&amp;pmid=14749714&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4-mol-15-136">4. <span class="element-citation">Jawaheer D, et al.  Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. <span><span class="ref-journal">Arthritis Rheum. </span>2003;<span class="ref-vol">48</span>:906–16.</span> [<a href="/pubmed/12687532" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Screening+the+genome+for+rheumatoid+arthritis+susceptibility+genes:+a+replication+study+and+combined+analysis+of+512+multicase+families&amp;author=D+Jawaheer&amp;volume=48&amp;publication_year=2003&amp;pages=906-16&amp;pmid=12687532&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5-mol-15-136">5. <span class="element-citation">Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. <span><span class="ref-journal">Arthritis Rheum. </span>1987;<span class="ref-vol">30</span>:1205–13.</span> [<a href="/pubmed/2446635" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=The+shared+epitope+hypothesis.+An+approach+to+understanding+the+molecular+genetics+of+susceptibility+to+rheumatoid+arthritis&amp;author=PK+Gregersen&amp;author=J+Silver&amp;author=RJ+Winchester&amp;volume=30&amp;publication_year=1987&amp;pages=1205-13&amp;pmid=2446635&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6-mol-15-136">6. <span class="element-citation">Vallbracht I, et al.  Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor iso-types in rheumatoid arthritis. <span><span class="ref-journal">Ann Rheum Dis. </span>2004;<span class="ref-vol">63</span>:1079–84.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1755115/">PMC free article</a>]</span> [<a href="/pubmed/15308516" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Diagnostic+and+clinical+value+of+anti-cyclic+citrullinated+peptide+antibodies+compared+with+rheumatoid+factor+iso-types+in+rheumatoid+arthritis&amp;author=I+Vallbracht&amp;volume=63&amp;publication_year=2004&amp;pages=1079-84&amp;pmid=15308516&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7-mol-15-136">7. <span class="element-citation">van Gaalen FA, et al.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. <span><span class="ref-journal">Arthritis Rheum. </span>2004;<span class="ref-vol">50</span>:2113–21.</span> [<a href="/pubmed/15248208" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Association+between+HLA+class+II+genes+and+autoantibodies+to+cyclic+citrullinated+peptides+(CCPs)+influences+the+severity+of+rheumatoid+arthritis&amp;author=FA+van+Gaalen&amp;volume=50&amp;publication_year=2004&amp;pages=2113-21&amp;pmid=15248208&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8-mol-15-136">8. <span class="element-citation">Meyer O, et al.  Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. <span><span class="ref-journal">Arthritis Res Ther. </span>2006;<span class="ref-vol">8</span>:R40.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1526612/">PMC free article</a>]</span> [<a href="/pubmed/16469118" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Res+Ther&amp;title=Serial+determination+of+cyclic+citrullinated+peptide+autoantibodies+predicted+five-year+radiological+outcomes+in+a+prospective+cohort+of+patients+with+early+rheumatoid+arthritis&amp;author=O+Meyer&amp;volume=8&amp;publication_year=2006&amp;pages=R40&amp;pmid=16469118&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9-mol-15-136">9. <span class="element-citation">Mierau R, Genth E. Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis. <span><span class="ref-journal">Clin Chem Lab Med. </span>2006;<span class="ref-vol">44</span>:138–43.</span> [<a href="/pubmed/16475897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem+Lab+Med&amp;title=Diagnosis+and+prognosis+of+early+rheumatoid+arthritis,+with+special+emphasis+on+laboratory+analysis&amp;author=R+Mierau&amp;author=E+Genth&amp;volume=44&amp;publication_year=2006&amp;pages=138-43&amp;pmid=16475897&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b10-mol-15-136">10. <span class="element-citation">Berglin E, et al.  Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. <span><span class="ref-journal">Ann Rheum Dis. </span>2006;<span class="ref-vol">65</span>:453–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1798112/">PMC free article</a>]</span> [<a href="/pubmed/16176994" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Radiological+outcome+in+rheumatoid+arthritis+is+predicted+by+presence+of+antibodies+against+cyclic+citrullinated+peptide+before+and+at+disease+onset,+and+by+IgA-RF+at+disease+onset&amp;author=E+Berglin&amp;volume=65&amp;publication_year=2006&amp;pages=453-8&amp;pmid=16176994&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11-mol-15-136">11. <span class="element-citation">Huizinga TW, et al.  Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. <span><span class="ref-journal">Arthritis Rheum. </span>2005;<span class="ref-vol">52</span>:3433–8.</span> [<a href="/pubmed/16255021" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Refining+the+complex+rheumatoid+arthritis+phenotype+based+on+specificity+of+the+HLA-DRB1+shared+epitope+for+antibodies+to+citrullinated+proteins&amp;author=TW+Huizinga&amp;volume=52&amp;publication_year=2005&amp;pages=3433-8&amp;pmid=16255021&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12-mol-15-136">12. <span class="element-citation">Karlson EW, et al.  Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. <span><span class="ref-journal">Ann Rheum Dis. </span>2008;<span class="ref-vol">67</span>:358–63.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2945890/">PMC free article</a>]</span> [<a href="/pubmed/17666451" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Associations+between+human+leukocyte+antigen,+PTPN22,+CTLA4+genotypes+and+rheumatoid+arthritis+phenotypes+of+autoantibody+status,+age+at+diagnosis+and+erosions+in+a+large+cohort+study&amp;author=EW+Karlson&amp;volume=67&amp;publication_year=2008&amp;pages=358-63&amp;pmid=17666451&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13-mol-15-136">13. <span class="element-citation">Plenge RM, et al.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1477–82.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2652744/">PMC free article</a>]</span> [<a href="/pubmed/17982456" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Two+independent+alleles+at+6q23+associated+with+risk+of+rheumatoid+arthritis&amp;author=RM+Plenge&amp;volume=39&amp;publication_year=2007&amp;pages=1477-82&amp;pmid=17982456&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14-mol-15-136">14. <span class="element-citation">Ding B, et al.  Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. <span><span class="ref-journal">Arthritis Rheum. </span>2009;<span class="ref-vol">60</span>:30–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2874319/">PMC free article</a>]</span> [<a href="/pubmed/19116921" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Different+patterns+of+associations+with+anti-citrullinated+protein+antibody-positive+and+anti-citrullinated+protein+antibody-negative+rheumatoid+arthritis+in+the+extended+major+histocompatibility+complex+region&amp;author=B+Ding&amp;volume=60&amp;publication_year=2009&amp;pages=30-8&amp;pmid=19116921&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15-mol-15-136">15. <span class="element-citation">Lee HS, et al.  Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. <span><span class="ref-journal">Arthritis Rheum. </span>2007;<span class="ref-vol">56</span>:1745–53.</span> [<a href="/pubmed/17530703" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Interaction+between+smoking,+the+shared+epitope,+and+anti-cyclic+citrullinated+peptide:+a+mixed+picture+in+three+large+North+American+rheumatoid+arthritis+cohorts&amp;author=HS+Lee&amp;volume=56&amp;publication_year=2007&amp;pages=1745-53&amp;pmid=17530703&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16-mol-15-136">16. <span class="element-citation">Irigoyen P, et al.  Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. <span><span class="ref-journal">Arthritis Rheum. </span>2005;<span class="ref-vol">52</span>:3813–8.</span> [<a href="/pubmed/16320316" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Regulation+of+anti-cyclic+citrullinated+peptide+antibodies+in+rheumatoid+arthritis:+contrasting+effects+of+HLA-DR3+and+the+shared+epitope+alleles&amp;author=P+Irigoyen&amp;volume=52&amp;publication_year=2005&amp;pages=3813-8&amp;pmid=16320316&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17-mol-15-136">17. <span class="element-citation">van der Helm-van Mil AH, et al.  The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. <span><span class="ref-journal">Arthritis Rheum. </span>2006;<span class="ref-vol">54</span>:1117–21.</span> [<a href="/pubmed/16572446" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=The+HLA-DRB1+shared+epitope+alleles+are+primarily+a+risk+factor+for+anti-cyclic+citrullinated+peptide+antibodies+and+are+not+an+independent+risk+factor+for+development+of+rheumatoid+arthritis&amp;author=AH+van+der+Helm-van+Mil&amp;volume=54&amp;publication_year=2006&amp;pages=1117-21&amp;pmid=16572446&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18-mol-15-136">18. <span class="element-citation">van der Helm-van Mil AH, et al.  The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. <span><span class="ref-journal">Arthritis Rheum. </span>2007;<span class="ref-vol">56</span>:425–32.</span> [<a href="/pubmed/17265477" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=The+HLA-DRB1+shared+epitope+alleles+differ+in+the+interaction+with+smoking+and+predisposition+to+antibodies+to+cyclic+citrullinated+peptide&amp;author=AH+van+der+Helm-van+Mil&amp;volume=56&amp;publication_year=2007&amp;pages=425-32&amp;pmid=17265477&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b19-mol-15-136">19. <span class="element-citation">Shadick NA, et al.  Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis. <span><span class="ref-journal">Ann Rheum Dis. </span>2007;<span class="ref-vol">66</span>:1497–502.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2111627/">PMC free article</a>]</span> [<a href="/pubmed/17491100" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Opposing+effects+of+the+D70+mutation+and+the+shared+epitope+in+HLA-DR4+on+disease+activity+and+certain+disease+phenotypes+in+rheumatoid+arthritis&amp;author=NA+Shadick&amp;volume=66&amp;publication_year=2007&amp;pages=1497-502&amp;pmid=17491100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b20-mol-15-136">20. <span class="element-citation">Purcell S, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–75.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;volume=81&amp;publication_year=2007&amp;pages=559-75&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b21-mol-15-136">21. <span class="element-citation">Plenge RM, et al.  TRAF1-C5 as a risk locus for rheumatoid arthritis — a genomewide study. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>:1199–209.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2636867/">PMC free article</a>]</span> [<a href="/pubmed/17804836" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=TRAF1-C5+as+a+risk+locus+for+rheumatoid+arthritis+—+a+genomewide+study&amp;author=RM+Plenge&amp;volume=357&amp;publication_year=2007&amp;pages=1199-209&amp;pmid=17804836&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b22-mol-15-136">22. <span class="element-citation">Tian C, et al.  Analysis and application of European genetic substructure using 300 K SNP information. <span><span class="ref-journal">PLoS Genetics. </span>2008;<span class="ref-vol">4</span>:e4.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2211544/">PMC free article</a>]</span> [<a href="/pubmed/18208329" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genetics&amp;title=Analysis+and+application+of+European+genetic+substructure+using+300+K+SNP+information&amp;author=C+Tian&amp;volume=4&amp;publication_year=2008&amp;pages=e4&amp;pmid=18208329&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b23-mol-15-136">23. <span class="element-citation">Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. <span><span class="ref-journal">Bioinformatics. </span>2005;<span class="ref-vol">21</span>:263–5.</span> [<a href="/pubmed/15297300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Haploview:+analysis+and+visualization+of+LD+and+haplotype+maps&amp;author=JC+Barrett&amp;author=B+Fry&amp;author=J+Maller&amp;author=MJ+Daly&amp;volume=21&amp;publication_year=2005&amp;pages=263-5&amp;pmid=15297300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b24-mol-15-136">24. <span class="element-citation">Frazer KA, et al.  A second generation human haplotype map of over 3.1 million SNPs. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">449</span>:851–61.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689609/">PMC free article</a>]</span> [<a href="/pubmed/17943122" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+second+generation+human+haplotype+map+of+over+3.1+million+SNPs&amp;author=KA+Frazer&amp;volume=449&amp;publication_year=2007&amp;pages=851-61&amp;pmid=17943122&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b25-mol-15-136">25. <span class="element-citation">Remmers EF, et al.  STAT4 and the risk of rheumatoid arthritis and systemic lupus erythe-matosus. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>:977–86.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2630215/">PMC free article</a>]</span> [<a href="/pubmed/17804842" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=STAT4+and+the+risk+of+rheumatoid+arthritis+and+systemic+lupus+erythe-matosus&amp;author=EF+Remmers&amp;volume=357&amp;publication_year=2007&amp;pages=977-86&amp;pmid=17804842&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b26-mol-15-136">26. <span class="element-citation">Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">447</span>:661–78.</span> et al. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2719288/">PMC free article</a>]</span> [<a href="/pubmed/17554300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genome-wide+association+study+of+14,000+cases+of+seven+common+diseases+and+3,000+shared+controls&amp;volume=447&amp;publication_year=2007&amp;pages=661-78&amp;pmid=17554300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b27-mol-15-136">27. <span class="element-citation">Raychaudhuri S, et al.  Common variants at CD40 and other loci confer risk of rheumatoid arthritis. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:1216–23.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2757650/">PMC free article</a>]</span> [<a href="/pubmed/18794853" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Common+variants+at+CD40+and+other+loci+confer+risk+of+rheumatoid+arthritis&amp;author=S+Raychaudhuri&amp;volume=40&amp;publication_year=2008&amp;pages=1216-23&amp;pmid=18794853&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2654848&amp;issue-id=179745&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm140697563855936title">Abstract</a></li><li><a href="#__sec1title">INTRODUCTION</a></li><li><a href="#__sec2title">METHODS</a></li><li><a href="#__sec7title">RESULTS</a></li><li><a href="#__sec10title">DISCUSSION</a></li><li><a href="#idm140697566812160title">ACKNOWLEDGMENTS</a></li><li><a href="#idm140697566810352title">Footnotes</a></li><li><a href="#idm140697564429680title">REFERENCES</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Molecular Medicine</span> are provided here courtesy of <strong>The Feinstein Institute for Medical Research at North Shore LIJ</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2654848/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2654848/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2654848/pdf/mol-15-136.pdf">PDF (1.7M)</a></li> | <li><a href="#" data-citationid="PMC2654848" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2654848%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2654848%2F&amp;text=Genome-Wide%20Association%20Study%20of%20Determinants%20of%20Anti-Cyclic%20Citrullinated%20Peptide%20Antibody%20Titer%20in%20Adults%20with%20Rheumatoid%20Arthritis" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2654848%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="19287509" data-aiid="2700727" data-aid="2654848" data-iid="179745" data-domainid="325" data-domain="molmed" data-accid="PMC2654848" data-md5="35e6d8a18627ea42e60894a3af4e341c"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T03:30:30-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE898AE9DD4F404100000000035F023D&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2654848%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=molmed&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2654848/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>